Itron, Inc. (NASDAQ:ITRI) SVP Michel Cadieux Sells 10,180 Shares

Itron, Inc. (NASDAQ:ITRI) SVP Michel Cadieux sold 10,180 shares of the firm’s stock in a transaction that occurred on Friday, September 10th. The stock was sold at an average price of $79.52, for a total transaction of $809,513.60. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.

NASDAQ:ITRI opened at $79.38 on Wednesday. Itron, Inc. has a one year low of $53.49 and a one year high of $122.31. The company has a debt-to-equity ratio of 0.40, a quick ratio of 1.29 and a current ratio of 1.64. The firm has a market cap of $3.59 billion, a P/E ratio of -149.77, a P/E/G ratio of 5.07 and a beta of 1.15. The firm has a 50-day simple moving average of $86.96 and a 200-day simple moving average of $91.69.

Itron (NASDAQ:ITRI) last posted its quarterly earnings results on Thursday, August 5th. The scientific and technical instruments company reported $0.28 EPS for the quarter, missing the consensus estimate of $0.48 by ($0.20). Itron had a negative net margin of 1.17% and a positive return on equity of 8.43%. The business had revenue of $489.41 million during the quarter, compared to the consensus estimate of $531.53 million. During the same quarter in the prior year, the firm posted $0.03 EPS. The company’s revenue for the quarter was down 4.0% compared to the same quarter last year. On average, research analysts predict that Itron, Inc. will post 1.3 EPS for the current fiscal year.

ITRI has been the topic of several recent research reports. Robert W. Baird downgraded shares of Itron from an “outperform” rating to a “neutral” rating and decreased their price target for the stock from $100.00 to $75.00 in a research report on Friday, August 6th. JPMorgan Chase & Co. raised their price objective on shares of Itron from $110.00 to $120.00 and gave the company an “overweight” rating in a research report on Wednesday, July 21st. Raymond James upgraded shares of Itron from an “outperform” rating to a “strong-buy” rating and set a $98.00 price objective on the stock in a research report on Friday, August 6th. Piper Sandler reduced their price target on shares of Itron from $103.00 to $90.00 and set an “overweight” rating on the stock in a report on Friday, August 6th. Finally, Canaccord Genuity reduced their price target on shares of Itron from $126.00 to $87.00 and set a “buy” rating on the stock in a report on Friday, August 6th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating, six have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and a consensus target price of $103.11.

Large investors have recently bought and sold shares of the company. Versant Capital Management Inc raised its holdings in shares of Itron by 185.1% in the 2nd quarter. Versant Capital Management Inc now owns 248 shares of the scientific and technical instruments company’s stock valued at $25,000 after purchasing an additional 161 shares in the last quarter. US Bancorp DE raised its holdings in shares of Itron by 69.2% in the 1st quarter. US Bancorp DE now owns 450 shares of the scientific and technical instruments company’s stock valued at $40,000 after purchasing an additional 184 shares in the last quarter. Barrett Asset Management LLC bought a new position in shares of Itron during the 1st quarter worth approximately $40,000. Archer Investment Corp raised its stake in shares of Itron by 33.1% during the 2nd quarter. Archer Investment Corp now owns 805 shares of the scientific and technical instruments company’s stock worth $80,000 after acquiring an additional 200 shares in the last quarter. Finally, Banque Cantonale Vaudoise raised its stake in shares of Itron by 72.6% during the 1st quarter. Banque Cantonale Vaudoise now owns 1,025 shares of the scientific and technical instruments company’s stock worth $91,000 after acquiring an additional 431 shares in the last quarter. Institutional investors and hedge funds own 97.69% of the company’s stock.

About Itron

Itron, Inc is a technology and services company, which engages in the provision of solutions that measure, manage, and analyze energy and water use. It operates through the following segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment includes hardware products used for measurement, control, or sensing that do not have communications capability embedded for use with its broader Itron systems.

Featured Article: Why are percentage gainers important?

Insider Buying and Selling by Quarter for Itron (NASDAQ:ITRI)

Receive News & Ratings for Itron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Itron and related companies with MarketBeat.com's FREE daily email newsletter.